King MS - Search Results

1

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA. Brown TT, et al. Among authors: king ms. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):554-61. doi: 10.1097/QAI.0b013e3181adce44. J Acquir Immune Defic Syndr. 2009. PMID: 19512937 Clinical Trial.

2

Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.

Campo RE, Da Silva BA, Cotte L, Gathe JC, Gazzard B, Hicks CB, Klein CE, Chiu YL, King MS, Bernstein BM. Campo RE, et al. Among authors: king ms. AIDS Res Hum Retroviruses. 2009 Mar;25(3):269-75. doi: 10.1089/aid.2008.0217. AIDS Res Hum Retroviruses. 2009. PMID: 19292590 Clinical Trial.

3

A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.

Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, King MS, Bernstein BM, Brun SC, Hanna GJ. Cameron DW, et al. Among authors: king ms. J Infect Dis. 2008 Jul 15;198(2):234-40. doi: 10.1086/589622. J Infect Dis. 2008. PMID: 18540803 Clinical Trial.

4

Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients.

King MS, Bernstein BM, Walmsley SL, Sherer R, Feinberg J, Sanne I, Cernohous P, Montaner JS, Brun SC, Sun E. King MS, et al. J Infect Dis. 2004 Jul 15;190(2):280-4. doi: 10.1086/422037. Epub 2004 Jun 11. J Infect Dis. 2004. PMID: 15216462 Clinical Trial.

5

Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.

Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, Foit C, Calhoun D, Bernstein B, Hanna GJ. Cameron DW, et al. Among authors: king ms. J Antimicrob Chemother. 2007 May;59(5):957-63. doi: 10.1093/jac/dkm029. Epub 2007 Mar 9. J Antimicrob Chemother. 2007. PMID: 17350990 Clinical Trial.

6

Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients.

Murphy RL, da Silva BA, Hicks CB, Eron JJ, Gulick RM, Thompson MA, McMillan F, King MS, Hanna GJ, Brun SC. Murphy RL, et al. Among authors: king ms. HIV Clin Trials. 2008 Jan-Feb;9(1):1-10. doi: 10.1310/hct0901-1. HIV Clin Trials. 2008. PMID: 18215977 Clinical Trial.

7

Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.

French MA, King MS, Tschampa JM, da Silva BA, Landay AL. French MA, et al. Among authors: king ms. J Infect Dis. 2009 Oct 15;200(8):1212-5. doi: 10.1086/605890. J Infect Dis. 2009. PMID: 19728788

8

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC, Kempf DJ, Mellors JW, Coffin JM, King MS. Palmer S, et al. Among authors: king ms. Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84. doi: 10.1073/pnas.0800050105. Epub 2008 Mar 10. Proc Natl Acad Sci U S A. 2008. PMID: 18332425 Free PMC article.

9

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.

Eron JJ, Feinberg J, Kessler HA, Horowitz HW, Witt MD, Carpio FF, Wheeler DA, Ruane P, Mildvan D, Yangco BG, Bertz R, Bernstein B, King MS, Sun E. Eron JJ, et al. Among authors: king ms. J Infect Dis. 2004 Jan 15;189(2):265-72. doi: 10.1086/380799. Epub 2004 Jan 7. J Infect Dis. 2004. PMID: 14722892 Clinical Trial.

10

Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.

Landay A, da Silva BA, King MS, Albrecht M, Benson C, Eron J, Glesby M, Gulick R, Hicks C, Kessler H, Murphy R, Thompson M, White AC Jr, Wolfe P, McMillan FI, Hanna GJ. Landay A, et al. Among authors: king ms. Clin Infect Dis. 2007 Mar 1;44(5):749-54. doi: 10.1086/511681. Epub 2007 Jan 25. Clin Infect Dis. 2007. PMID: 17278071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters